Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

May 27, 2025

Study Completion Date

July 13, 2025

Conditions
Atopic Dermatitis (AD)
Interventions
DRUG

Roflumilast Cream 0.15%

Roflumilast cream 0.15% is applied once daily for 4 weeks

DRUG

Vehicle cream

Vehicle cream is applied once daily for 4 weeks

Trial Locations (61)

Unknown

The Second affiliated Hospital of Wannan Medical College, Wuhu

Beijing Aerospace General Hospital, Beijing

Beijing Children's Hospital, Beijing

Beijing Tongren Hospital, CMU, Beijing

Beijing Tsinghua Changgung Hospital, Beijing

Chongqing Medical University Affiliated Second Hospital, Chongqing

People's Hospital Affiliated to Chongqing Three Gorges Medical College, Chongqing

Fujian Medical University Union Hospital, Fuzhou

The Second affiliated Hospital of Xiamen Medical College, Xiamen

Dongguan People's Hospital, Dongguan

The Sixth People's Hospital of Dongguan, Dongguan

Dermatology Hospital of Southern Medical University, Guangzhou

The Second affiliated Hospital of Guangzhou Medical University, Guangzhou

Shenzhen Children's Hospital, Shenzhen

Union Shenzhen Hospital, Shenzhen

Liuzhou People's Hospital, Liuzhou

Hainan General Hospital, Haikou

The Fifth People's Hospital of Hainan Province, Haikou

Shijiazhuang People's Hospital, Shijiazhuang

TCM Hospital of Shi Jia Zhuang City, Shijiazhuang

Xingtai People's Hospital, Xingtai

The Second Hospital affiliated to Henan University of Science and Technology, Luoyang

Nanyang Central Hospital, Nanyang

Sanmenxia Central Hospital, Sanmenxia

Henan Children's Hospital Zhengzhou Children's Hospital, Zhengzhou

Zhengzhou Central Hospital, Zhengzhou

Jingzhou Central Hospital, Jingzhou

Renmin Hospital of Wuhan University, Wuhan

Yichang Central People's Hospital, Yichang

The First People's Hospital of Changde City, Changde

Hunan Children's Hospital, Changsha

The Second Xiangya Hospital of Central South University, Changsha

Xiangya Hospital, Changsha

Sir Run Run Hospital Nanjing Medical University, Nanjing

J.Y Hospital of TCM, Wuxi

People's hospital of Wuxi, Wuxi

Wuxi Second People's Hospital, Wuxi

Affiliated Hospital of Jiangsu University, Zhenjiang

Dermatology Hospital of Jiangxi Province, Nanchang

The Second affiliated Hospital of Nanchang University, Nanchang

The First Bethune Hospital of Jilin University, Changchun

Dalian Municipal Women and Children's Medical Center, Dalian

Panjin Liaohe Oilfield Gem Flower Hospital, Panjin

The First affiliated Hospital of Baotou College, Baotou

Jinan Central Hospital, Jinan

Qilu Hospital of Shandong University, Jinan

Liaocheng People's Hospital, Liaocheng

Hiser Medical Center of Qingdao, Qingdao

Huashan Hospital, Fudan University, Shanghai

Shanghai Children's Hospital, Shanghai

The Second affiliated Hospital of Xi'an Jiaotong University, Xi’an

Chengdu Second People's Hospital, Chengdu

Chengdu Women's and Children's Central Hospital, Chengdu

Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital, Chengdu

Hangzhou First People's Hospital, Hangzhou

The First Hospital of Jiaxing, Jiaxing

The Second Hospital of Jiaxing, Jiaxing

The Second Hospital of Ningbo, Ningbo

Taizhou Central Hospital, Taizhou

China

Kunming Children's Hospital, Kunming

Dalian Dermatology Hospital, Dalian

All Listed Sponsors
lead

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

INDUSTRY

NCT06631170 - Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter